Publications scientifiques en 2014

Depuis le 02/06/2023

  1. Chronic venous disease and the genetic influence.
    Boisseau MR.
    Phlebolymphology. 2014
  2. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.
    Avillach P, Salvo F, Thiessard F, Miremont-Salamé G, Fourrier-Reglat A, Haramburu F, Bégaud B, Moore N, Pariente A; l'Association des Centres Régionaux de Pharmacovigilance.
    Pharmacoepidemiol Drug Saf. 2014
  3. Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study.
    Fourrier-Réglat A, Noize P, Facon T, Fermand JP, Fitoussi O, Marit G, Thomaré P, Robinson P, Bignon E, Jové J, Lassalle R, Rouyer M, Grelaud A, Moore N; VESUVE Study Group.
    Leuk Lymphoma. 2014
  4. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, Lavernhe G, Mann M, Pollet C, Robinson P, Jové J, Moore N, Fourrier-Réglat A; EULEV study group.
    Eur J Paediatr Neurol. 2014
  5. Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.
    Duong M, Salvo F, Pariente A, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N.
    Br J Clin Pharmacol. 2014
  6. Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.
    Moore N, Salvo F, Duong M, Blin P, Pariente A.
    Expert Opin Drug Saf. 2014
  7. Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.
    Bezin J, Pariente A, Lassalle R, Dureau-Pournin C, Abouelfath A, Robinson P, Moore N, Droz-Perroteau C, Fourrier-Reglat A.
    Eur J Clin Pharmacol. 2014
  8. Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort.
    Fourrier-Réglat A, Smith D, Rouyer M, Bénichou J, Guimbaud R, Bécouarn Y, Bernard O, Noize P, Moore N, Ravaud A; ETNA study group.
    Target Oncol. 2014
  9. Effect of Cydonia oblonga Mill. leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia.
    Abliz A, Aji Q, Abdusalam E, Sun X, Abdurahman A, Zhou W, Moore N, Umar A.
    J Ethnopharmacol. 2014
  10. Effect of Ocimum basilicum L. on cyclo-oxygenase isoforms and prostaglandins involved in thrombosis.
    Umar A, Zhou W, Abdusalam E, Tursun A, Reyim N, Tohti I, Moore N.
    J Ethnopharmacol. 2014
  11. Characteristics of patients consulting their regular primary care physician according to their prescribing preferences for homeopathy and complementary medicine.
    Lert F, Grimaldi-Bensouda L, Rouillon F, Massol J, Guillemot D, Avouac B, Duru G, Magnier AM, Rossignol M, Abenhaim L, Bégaud B; EPI3-LA-SER Group.
    Homeopathy. 2014
  12. Linagliptin for elderly patients with type 2 diabetes.
    Salvo F, Moore N, Pariente A.
    Lancet. 2014
  13. Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Théophile H, David XR, Miremont-Salamé G, Haramburu F.
    Dig Liver Dis. 2014
  14. Effect of Cydonia oblonga Mill. fruit and leaf extracts on blood pressure and blood rheology in renal hypertensive rats.
    Zhou W, Abdusalam E, Abliz P, Reyim N, Tian S, Aji Q, Issak M, Iskandar G, Moore N, Umar A.
    J Ethnopharmacol. 2014
  15. Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control.
    Molimard M, Mala L, Bourdeix I, Le Gros V.
    Respir Med. 2014
  16. Modafinil improves real driving performance in patients with hypersomnia: a randomized double-blind placebo-controlled crossover clinical trial.
    Philip P, Chaufton C, Taillard J, Capelli A, Coste O, Léger D, Moore N, Sagaspe P.
    Sleep. 2014
  17. Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation.
    Salvo F, Raschi E, Moretti U, Chiarolanza A, Fourrier-Réglat A, Moore N, Sturkemboom M, De Ponti F, Poluzzi E, Pariente A.
    Eur J Clin Pharmacol. 2014
  18. Risk of major bleeding and the standard doses of dabigatran.
    Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.
    Eur J Intern Med. 2014
  19. Guidance on handheld inhalers in asthma and COPD guidelines.
    Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J.
    Respir Med. 2014
  20. Management of Upper Respiratory Tract Infections by Different Medical Practices, Including Homeopathy, and Consumption of Antibiotics in Primary Care: The EPI3 Cohort Study in France 2007-2008.
    Grimaldi-Bensouda L, Bégaud B, Rossignol M, Avouac B, Lert F, Rouillon F, Bénichou J, Massol J, Duru G, Magnier AM, Abenhaim L, Guillemot D.
    PLoS One. 2014
  21. Effect of Cydonia oblonga Mill. leaf extracts or captopril on blood pressure and related biomarkers in renal hypertensive rats.
    Zhou WT, Abdurahman A, Abdusalam E, Yiming W, Abliz P, Aji Q, Issak M, Iskandar G, Moore N, Umar A.
    J Ethnopharmacol. 2014
  22. Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studies.
    Salvo F, Antoniazzi S, Duong M, Molimard M, Bazin F, Fourrier-Réglat A, Pariente A, Moore N.
    Expert Opin Drug Saf. 2014
  23. Effect of Bridelia ferruginea Benth (Euphorbiaceae) ethyl acetate and acetone fractions on insulin resistance in fructose drinking mice.
    Bakoma B, Berké B, Eklu-Gadegbeku K, Agbonon A, Aklikokou K, Gbeassor M, Moore N.
    J Ethnopharmacol. 2014
  24. Effects of Cydonia oblonga Miller extracts on blood hemostasis, coagulation and fibrinolysis in mice, and experimental thrombosis in rats.
    Zhou W, Abdurahman A, Umar A, Iskander G, Abdusalam E, Berké B, Bégaud B, Moore N.
    J Ethnopharmacol. 2014
  25. Fibrates and Risk of Cancer in Tissues with High PPAR-? Concentration: A Nested Case-Control Study.
    Salvo F, Bazin F, Kostrzewa A, Bandre C, Robinson P, Moore N, Bégaud B, Pariente A.
    Drug Saf. 2014
  26. Levels and determinants of pesticide exposure in re-entry workers in vineyards: results of the PESTEXPO study.
    Baldi I, Lebailly P, Bouvier G, Rondeau V, Kientz-Bouchart V, Canal-Raffin M, Garrigou A.
    Environ Res. 2014
  27. New oral anticoagulants (NOAC) and liver injury.
    Moore N, Blin P, Gulmez SE.
    J Hepatol. 2014
  28. Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions.
    Gotta V, Bouchet S, Widmer N, Schuld P, Decosterd LA, Buclin T, Mahon FX, Csajka C, Molimard M.
    Leuk Res. 2014
  29. Integrated care pathways for airway diseases (AIRWAYS-ICPs).
    Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, Annesi-Maesano I, Anto JM, Bachert C, Baena-Cagnani CE, Bai C, Baigenzhin A, Barbara C, Barnes PJ, Bateman ED, Beck L, Bedbrook A, Bel EH, Benezet O, Bennoor KS, Benson M, Bernabeu-Wittel M, Bewick M, Bindslev-Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Bousquet PJ, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos PA, Camuzat T, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chkhartishvili E, Chavannes NH, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Cruz AA, Custovic A, Dahl R, Dahlen SE, De Blay F, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dubakiene R, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Frith P, Furber A, Gaga M, Garces J, Garcia-Aymerich J, Gamkrelidze A, Gonzales-Diaz S, Gouzi F, Guzman MA, Haahtela T, Harrison D, Hayot M, Heaney LG, Heinrich J, Hellings PW, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim JR, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Khaltaev N, Kolek V, Kowalski ML, Kull I, Kuna P, Kvedariene V, Le LT, Lodrup Carlsen KC, Louis R, MacNee W, Mair A, Majer I, Manning P, de Manuel Keenoy E, Masjedi MR, Melen E, Melo-Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, N'Diaye M, Nafti S, Nekam K, Neou A, Nicod L, O'Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Robine JM, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Rosado-Pinto J, Ryan D, Samolinski B, Sanchez-Borges M, Schunemann HJ, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, Tellier V, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valiulis A, Valovirta E, Van Ganse E, Vandenplas O, Vasankari T, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wahn U, Wallaert B, Whalley B, Wickman M, Williams DM, Wilson N, Yawn BP, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zhong N, Zidarn M, Zuberbier T.
    Eur Respir J. 2014
  30. [How people use the internet to find information on medicines?].
    Gouverneur A, Bourenane H, Chung A, Daguerre C, Devarieux M, Malifarge L, Durieu du Pradel P, Haramburu F, Noize P.
    Therapie. 2014
  31. Long-term chronic diseases and crash responsibility: A record linkage study.
    Orriols L, Avalos-Fernandez M, Moore N, Philip P, Delorme B, Laumon B, Gadegbeku B, Salmi LR, Lagarde E.
    Accid Anal Prev. 2014
  32. Performance of the Standardised MedDRA(®) Queries for Case Retrieval in the French Spontaneous Reporting Database.
    Géniaux H, Assaf D, Miremont-Salamé G, Raspaud B, Gouverneur A, Robinson P, Pariente A, Salvo F.
    Drug Saf. 2014
  33. Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases.
    Streicher C, Djabarouti S, Xuereb F, Lazaro E, Legeron R, Bouchet S, Greib C, Breilh D, Pellegrin JL, Viallard JF.
    Br J Clin Pharmacol. 2014
  34. Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations.
    Molimard M, Bernaud C, Lechat P; participants of round table n6 of Giens XXIX: Bejan-Angoulvant Theodora 4 Benattia Cherif 5 Benkritly Amel 6, Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M.
    Therapie. 2014
  35. Benzodiazepine use and risk of Alzheimer's disease: case-control study.
    Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Bégaud B.
    BMJ. 2014
  36. [SIGAPS: a software package for the evaluation of medical publications].
    Derancourt C, Devos P, Moore N, Rouvillain JL.
    Ann Dermatol Venereol. 2014
  37. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
    Daveluy A, Géniaux H, Thibaud L, Mallaret M, Miremont-Salamé G, Haramburu F.
    Therapie. 2014
  38. Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock.
    Picard W, Bazin F, Clouzeau B, Bui HN, Soulat M, Guilhon E, Vargas F, Hilbert G, Bouchet S, Gruson D, Moore N, Boyer A.
    Antimicrob Agents Chemother. 2014
  39. Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma.
    Suttle AB, Ball HA, Molimard M, Hutson TE, Carpenter C, Rajagopalan D, Lin Y, Swann S, Amado R, Pandite L.
    Br J Cancer. 2014
  40. Scoring of medical publications with SIGAPS software: Application to orthopedics.
    Rouvillain JL, Derancourt C, Moore N, Devos P.
    Orthop Traumatol Surg Res. 2014